ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date

Monday, November 9, 2015

9:00AM-11:00AM
Abstract Number: 1216
The Clinical and Ultrasonographic Presentation of Seronegative RA Is More Severe Compared to Seropositive RA in an Inception Cohort of DMARD-Naïve Patients Classified According to the 2010 ACR/EULAR Criteria
Epidemiology and Public Health Poster II: Pathogenesis and Treatment of Systemic Inflammatory Diseases
9:00AM-11:00AM
Abstract Number: 1535
The Clinical Impact of Overweight in Rheumatoid Arthritis Patients: Comparison Between Korean and Other Countries within the Comora Study
Rheumatoid Arthritis - Clinical Aspects Poster II
9:00AM-11:00AM
Abstract Number: 1183
The Country Where You Perform Your Rheumatology Training Is Associated with the Acquired Confidence, the Education Received and the Assessment in Core Competences
Education Poster I
9:00AM-11:00AM
Abstract Number: 1560
The Effect of Anti Estrogen Therapy (AET) on Rheumatoid Arthritis
Rheumatoid Arthritis - Clinical Aspects Poster II
9:00AM-11:00AM
Abstract Number: 1426
The Effect of Anti-Interleukin-6 Receptor Antibody in Ovariectomized Mice
Pain: Basic and Clinical Aspects Poster
9:00AM-11:00AM
Abstract Number: 1429
The Effect of Gabapentin and Cyclooxygenase Inhibitors on Evoked and Ongoing Pain-like Behavior in Two Arthritis Models in Mice
Pain: Basic and Clinical Aspects Poster
9:00AM-11:00AM
Abstract Number: 1449
The Effect of IL-1 Receptor Antagonist Anakinra (Kineret®) on Measures of Central Nervous System Inflammation and Headaches in Pediatric Patients with Severe Cryopyrin-Associated Periodic Syndromes
Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases
9:00AM-11:00AM
Abstract Number: 1561
The Effect of TNF Blockers on Bone Mineral Density in Rheumatoid Arthritis Patients Receiving Bisphosphonate
Rheumatoid Arthritis - Clinical Aspects Poster II
9:00AM-11:00AM
Abstract Number: 1193
The Effectiveness of Low-Impact Exercise Program on Musculoskeletal Health of Asian Older Adults
Education Poster (ARHP): Education/Community Programs
9:00AM-11:00AM
Abstract Number: 1634
The Effects of Glucocorticoids on the Efficacy of Tofacitinib As Monotherapy and in Combination Therapy with Nonbiologic Dmards: An Analysis of Data from Six Phase 3 Studies
Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster II
9:00AM-11:00AM
Abstract Number: 1192
The F-Word: Why Is Talking about Fatigue so Hard?
Education Poster (ARHP): Education/Community Programs
9:00AM-11:00AM
Abstract Number: 1812
The First Randomized Control Trial to Evaluate the Effectiveness of Bortezomib for Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session II
9:00AM-11:00AM
Abstract Number: 1105
The IgG/IgG4 mRNA Ratio By Quantitative PCR Accurately Diagnoses IgG4-Related Disease and Predicts Treatment Response
B cell Biology and Targets in Rheumatolid Arthritis and other Autoimmune Disease Poster
9:00AM-11:00AM
Abstract Number: 1614
The Impact of High Risk Susceptible Gene  LILRA3  on Joint Inflammation in Rheumatoid Arthritis
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster II
9:00AM-11:00AM
Abstract Number: 1557
The Impact of Hindfoot Deformity on Disability of Korean Patients with Rheumatoid Arthritis
Rheumatoid Arthritis - Clinical Aspects Poster II
  • «Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 72
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology